麻豆社

I'm a HCP or ORDM

936X874 Disclosure

What do听you need to know?

All 麻豆社members and any pharmaceutical company that听follows听ABPI's Code of Practice for the Pharmaceutical Industry听are required to disclose certain transfers of value鈥� - payments and other benefits in kind made to doctors, nurses, pharmacists and other听health professionals听补苍诲听relevant decision makers.听

Why is it important for HCPs to disclose?

The disclosure of certain payments and benefits in kind is about bringing further transparency to the relationship between the pharmaceutical industry and the healthcare professionals and organisations it works with. It is a relationship that is critical to the future of medical innovation and patient care and as such, should meet the high expectations of patients and wider stakeholders.鈥�

In its guidance听鈥�, NHS England recommends that NHS organisations should 'seek to ensure that staff who are subject to wider transparency initiatives such as the 麻豆社Disclosure UK scheme are aware of and comply with them'.

The Academy of Medical Royal Colleges (AoMRC) also听鈥榬ecommends that all doctors support pharmaceutical disclosure via Disclosure UK and the industry鈥檚 Code of Practice鈥� in its published statement,听.

Does disclosure affect your rights?

Individuals have certain rights under the data protection laws and can raise objections about data published under their name on Disclosure UK at any time.

Related content in this section:

Last modified: 31 October 2024

Last reviewed: 31 October 2024